Hassett v. Dafoe

OPINION BY

BOWES, J.:

PLIVA, Inc. and Teva Pharmaceutical USA, Inc., (“Generic Defendants”) appeal from November 18, 2011 order overruling their preliminary objections in the nature of a demurrer to a master complaint filed by Paul E. Hassett, who was allegedly injured after ingesting metoclopramide.1 The Generic Defendants assert that all of Mr. Hassett’s claims against generic manufacturers of metoclopramide, regardless of the legal theory advanced and without consideration of the state law applicable, *206are failure-to-warn claims. They continue that all causes of action are indistinguishable…